Report me for selling fake medicine? Why are you crying when your illness relapses?

Moreover, although his teacher was a professor and vice president of Tianfu Medical College, he had no power and was even marginalized and always felt frustrated.

It’s not that his academic ability is poor, on the contrary, it’s because his academic ability is too strong and he is fully focused on academic studies.

As a result, they ignored the ways of the world, did not join small circles, and were unwilling to associate with others, which eventually led to being excluded.

Every time I applied for a budget for an experimental project, it was basically rejected. Even if it was occasionally approved, it would be cut in half, and the conditions in the laboratory were getting worse and worse.

Without enough connections, you will get fewer and fewer resources in school.

In this case, Chen Xuan might as well pick up the teacher.

It can help the teacher realize his ambition and help him at the same time, which is better than wasting time in school.

With him, you can definitely get the best resources, without worrying about being restricted, and without having to deal with social relationships, so you can concentrate on your own experiments.

Chen Xuan always remembers the kindness Yang Qingfeng has shown him.

The reason why I didn't go to see him for so long was mainly because he was waiting for a suitable opportunity.

And now, this opportunity has come.

"Okay, I'll make arrangements right away."

Luo Shiyun nodded and left.

Now that Antai Pharmaceutical Group’s new drug clinical trial has been approved, there are still many things that need to be arranged.

External statements, contacting insurance companies, determining specific insurance agreements, finding suitable test candidates... and so on!

…………

Luo Shiyun is very efficient.

Not long after, the announcement from Antai Pharmaceutical Group came out.

In addition to announcing clinical trials, the indications of the new drug were also stated.

Although this new drug is mainly used to treat lung cancer, it also has many other indications that are suitable for treatment with this new drug.

This clinical trial will need to test multiple indications at the same time to ensure that the new drug can become the main treatment for these diseases after it is launched on the market.

Therefore, it is necessary to disclose it in advance.

Fortunately, when recruiting later, we can find suitable patients. We can't just let all the patients come and try their luck, and then ask them to go back if they are not suitable.

Now that it is made public, patients with these diseases can come forward on their own initiative, thus reducing the communication time for both parties.

"Holy crap, Chen Xuan's new drug is finally going to start clinical trials?"

"This is incredibly fast. It seems he developed it a long time ago and is just waiting for the paperwork to be approved."

"Awesome, Klas! This is actually a special medicine for treating lung cancer. It's awesome, but I wonder how effective it is?"

"I feel the effect should not be worse than the liver cancer special effect. This can be seen from Chen Xuan's previous introduction. At least it should be a special effect drug of the same level."

"If lung cancer can really be cured, then Chen Xuan's research and development level can be called the best in the world. No laboratory can compare to him. He is a super genius."

"It's not just lung cancer! Didn't you see the whole list of indications? It even has some effect on stomach cancer. It's fucking amazing."

"If this drug could be marketed, who knows how many people it could cure. Chen Xuan's move is simply amazing."

After the announcement of Antai Pharmaceutical Group came out,

Countless netizens across the Internet were excited.

They didn't expect that Chen Xuan's new drug could start clinical trials so soon.

No one expected that this new drug would actually be a specific drug for treating lung cancer. The number of people who need this specific drug is far greater than that for liver cancer drugs.

What shocked them even more was the indications of this new drug. The large number of indications made their scalps tingle.

Generally, new drugs begin clinical trials.

There are not too many indications, one or two is already very good.

Most of them were discovered to have other indications during clinical trials and were then gradually added.